中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 35 Issue 7
Jul.  2019
Turn off MathJax
Article Contents

Role of cholestatic liver disease-related genes in intrahepatic cholestasis of pregnancy

DOI: 10.3969/j.issn.1001-5256.2019.07.006
Research funding:

 

  • Received Date: 2019-04-23
  • Published Date: 2019-07-20
  • Intrahepatic cholestasis of pregnancy ( ICP) is the most common liver disease during pregnancy. ICP usually occurs in late pregnancy, with main manifestations of pruritus, jaundice, and increases in serum levels of total bile acid and aminotransferases found by laboratory examination. ICP has great impact on the fetus and may lead to preterm birth, stillbirth, and deformity. ICP has complex etiologies, and studies have shown that genetic, metabolic, immunological, and hormonal factors may contribute to the onset of ICP. The genes associated with cholestasis, such as ABCB11, ABCB4, ATP8 B1, and FXR, are associated with the genetic susceptibility of ICP. This article reviews the association between cholestasis-related genes and ICP.

     

  • loading
  • [1] BICOCCA MJ, SPERLING JD, CHAUHAN SP. Intrahepatic cholestasis of pregnancy:Review of six national and regional guidelines[J]. Eur J Obstet Gynecol Reprod Biol, 2018, 231:180-187.
    [2] BROUWERS L, KOSTER MP, PAGE-CHRISTIAENS GC, et al. Intrahepatic cholestasis of pregnancy:Maternal and fetal outcomes associated with elevated bile acid levels[J]. Am J Obstet Gynecol, 2015, 212 (1) :100. e1-e7.
    [3] TAKATSU H, TANAKA G, SEGAWA K, et al. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane[J]. J Biol Chem, 2014, 289 (48) :33543-33556.
    [4] KLINDT C, BONUS M, BAUMANN U, et al. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants[J].J Hepatol, 2017, 67 (6) :1253-1264.
    [5] WANG L, SOROKA CJ, BOYER JL. The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II[J]. J Clin Invest, 2002, 110 (7) :965-972.
    [6] BULL LN, THOMPSON RJ. Progressive familial intrahepatic cholestasis[J]. Clin Liver Dis, 2018, 22 (4) :657-669.
    [7] DROGE C, BONUS M, BAUMANN U, et al. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants[J].J Hepatol, 2017, 67 (6) :1253-1264.
    [8] SAMBROTTA M, STRAUTNIEKS S, PAPOULI E, et al. Mutations in TJP2 cause progressive cholestatic liver disease[J].Nature Genetics, 2014, 46 (4) :326-328.
    [9] GISSEN P, ARIAS IM. Structural and functional hepatocyte polarity and liver disease[J]. J Hepatol, 2015, 63 (4) :1023-1037.
    [10] CARIELLO M, PICCININ E, GARCIA-IRIGOYEN O, et al. Nuclear receptor FXR, bile acids and liver damage:Introducing the progressive familial intrahepatic cholestasis with FXR mutations[J]. Biochim Biophys Acta, 2018, 1864 (4) :1308-1318.
    [11] MASSAFRA V, van MIL SWC. Farnesoid X receptor:A"homeostat"for hepatic nutrient metabolism[J]. Biochim Biophys Acta, 2018, 1864 (1) :45-59.
    [12] GOMEZ-OSPINA N, POTTER CJ, XIAO R, et al. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis[J]. Nat Commun, 2016, 7:107-113.
    [13] KNOWLES BC, ROLAND JT, KRISHNAN M, et al. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease[J]. J Clin Invest, 2014, 124 (7) :2947-2962.
    [14] GONZALES E, TAYLOR SA, DAVIT-SPRAUL A, et al. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease[J]. Hepatology, 2017, 65 (1) :164-173.
    [15] QIU YL, GONG JY, WANG JS, et al. Defects in myosin VB are associated with a spectrum of previously undiagnosed lowγ-glutamyl transferase cholestasis[J]. Hepatology, 2017, 65 (5) :1655-1699.
    [16] THOMPSON RJ, BULL LN. Treating genetic disease:Expanding the options[J]. Hepatology, 2015, 62 (2) :349-351.
    [17] DIXON PH, WILLIAMSON C. The molecular genetics of intrahepatic cholestasis of pregnancy[J]. Obstet Med, 2008, 1 (2) :65-71.
    [18] GERMAIN AM, KATO S, CARVAJAL JA, et al. Bile acids increase response and expression of human myometrial oxytocin receptor[J]. Am J Obstet Gynecol, 2003, 189 (2) :577-582.
    [19] JACQUEMIN E, CRESTEIL D, MANOUVRIER S, et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy[J]. Lancet, 1999, 353 (9148) :210-211.
    [20] DIXON PH, WILLIAMSON C. The pathophysiology of intrahepatic cholestasis of pregnancy[J]. Clin Res Hepatol Gastroenterol, 2016, 40 (2) :141-153.
    [21] PHDIXON N, WEERASEKERA KJ, LINTON O, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy:Evidence for a defection protein trafficking[J]. Hum Mol Genet, 2000, 9 (8) :1209-1217.
    [22] ELORANTA ME, HAKLI T, HIHUNEN M, et al. Association of single nucleotide polymorphisms of the bile salt export pump gene with intrahepatic cholestasis of pregnancy[J]. Seand J Gastroenterol, 2003, 38 (6) :648-652.
    [23] GEENES V, CHAMBERS J, KHURANA R, et al. Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2015, 189:59-63.
    [24] STRAUTNIEKS SS, BYRNE JA, PAWLIKOWSKA L, et al. Severe bile salt export pump deficiency:82 different ABCB11mutations in 109 families[J]. Gastroenterology, 2008, 134 (4) :1203-1214.
    [25] LANG T, HABERL M, JUNG D, et al. Genetie variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11) [J].Drug Metab Dispos, 2006, 34 (9) :1582-1599.
    [26] KEITEL V, VOGT C, HFIUSSINGER D, et al. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy[J]. Gastroenterology, 2006, 131 (2) :624-629.
    [27] DENG R, YANG D, RADKE A, et al. The hypolipidemic agent gugguls terone regulates the expression of burn bile salt export pump:Dominance of transactivation over farsenoid X receptor-mediated antagonism[J]. J Pharmacol ExpTher, 2007, 320 (3) :1153-1162.
    [28] VALLEJO M, BFIZ O, SERRANO MA, et al. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic eholestasis of pregnancy[J]. J Hepatol, 2006, 44 (6) :150-1157.
    [29] MULLENBAEH R, BENNETT A, TETLOW N, et al. ATP8B1mutations in British cases with intrahepatic cholestasis of pregnancy[J]. Gut, 2005, 54 (6) :829.
    [30] PAINTER JN, SAVANDER M, ROPPONEN A, et al. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy[J]. Eur J Hum Genet, 2005, 13 (4) :435-439.
    [31] DIXON PH, SAMBROTTA M, CHAMBERS J, et al. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy[J]. Sci Rep, 2017, 7 (1) :11823.
    [32] van MIL SW, MILONA A, DIXON PH, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy[J]. Gastroenterology, 2007, 133 (2) :507-516.
    [33] SOOKOIAN S, CASTANO G, BURGUENO A, et al. Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy[J]. J Hepatol, 2008, 48 (1) :125-132.
    [34] GEENES V, CHAPPELL LC, SEED PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes:A prospective population-based case control study[J]. Hepatology, 2014, 59 (4) :1482-1491.
    [35] YEAP SP, HARLEY H, THOM R, et al. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy:Diagnostic and management implications[J]. J Gastroenterol Hepatol, 2019, 34 (2) :425-435.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1454) PDF downloads(413) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return